Joseph Pinkhas
Surgery · Port Jefferson, NYNPI 1568721264
Payments from drug & device makers
What this record shows
This record is dominated by education: $96,000 of the $121,746 with a category attached, or 78.9%. Intuitive Surgical accounts for 95.6% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2023 at $44,114 and has fallen 74.4% since, to $11,301 in 2025. Among surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 401 payments — averaging $303.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$116K
- Integra Lifesciences Corporation$2K
- Davol Inc.$569
- Tactile Systems Technology Inc$543
- THD America, Inc.$491
- TELA Bio, Inc.$445
- plus $2K from 16 others
What the payments were for
- Speaking & faculty fees$4,5004%
- Travel & lodging$8,1307%
- Food & beverage$13,02911%
- Education$96,00079%
- Gifts$870%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 249 | $116,356 |
| Integra Lifesciences Corporation | 76 | $1,825 |
| Davol Inc. | 4 | $569 |
| Tactile Systems Technology Inc | 27 | $543 |
| THD America, Inc. | 3 | $491 |
| TELA Bio, Inc. | 9 | $445 |
| Smith+Nephew | 4 | $274 |
| Innocoll Pharmaceuticals Limited | 8 | $212 |
| Nevro Corp. | 5 | $211 |
| Boston Scientific | 1 | $136 |
| Lifenet Health | 1 | $126 |
| Enterra Medical, Inc. | 1 | $117 |
| W. L. Gore & Associates, Inc. | 1 | $103 |
| Organogenesis Inc. | 3 | $103 |
| Inspire Medical Systems, Inc. | 2 | $69 |
| Kerecis Limited | 1 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Exact Sciences | 1 | $22 |
| AbbVie | 1 | $21 |
| Heron Therapeutics, Inc. | 1 | $20 |
| Novo Nordisk | 1 | $20 |
| Bioventus LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$108,253
- DAVINCI XI$3,000
- DA VINCI SP$2,000
- INTEGRA$612
- Phasix Mesh$395
- Ovitex$273
- INTEGRA DERMAL REGENERATION TEMPLATE$255
- OMNIGRAFT$153
- SURGIMEND$153
- SpyGlass Discover$136
- Senza$132
- TheraGenesis Wound Matrix$126
- ACTICOAT 4" X 4"$117
- ALLEVYN HEEL 10.5CM X 13.5CM CTN 5$117
- Iodosorb Ointment 40g USA$117
- COLLAGENASE SANTYL$117
- XARACOLL$112
- GORE SYNECOR Biomaterial$103
- PRIMATRIX$102
How this compares
$121,746 in reported general payments places this provider in the 95th percentile of 1,596 surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 15 | $15,060 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $274 | $15,06015 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,596 surgery providers in New York.
Other surgery in Port Jefferson
- Hesham AtwaPort Jefferson$110K
- Ashish AgarwalaPort Jefferson$106K
- Arif AhmadPort Jefferson$60K
- Cheguevara AfanehNew York$1.4M
- Flavio Malcher Martins de OliveiraNew York$695K
- Yuri NovitskyNew York$548K
- Rasa ZarnegarNew York$478K
- Tanuja DamaniNew York$459K
- Benjamin SadowitzSyracuse$419K
- Stephen GoldstoneNy$386K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.